TrialJournal of gynecologic oncology2023

A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma.

John P Micha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.